7V7 Stock Price and Chart — SWB:7V7 — TradingView

Overview

About Acticor Biotech

Acticor Biotech SAS engages in the research and development of an antithrombotic agent for the treatment of the acute thrombotic diseases. It specializes on ischemic stroke. The company was founded on November 26, 2013 and is headquartered in Paris, France.

Financials

Performance

Revenue to profit conversion

Debt level and coverage

Earnings

Next:—

Seasonals

Displays a symbol's price movements over previous years to identify recurring trends.

Depending on the exchange, the stock ticker may vary. For instance, on SWB exchange Acticor Biotech stocks are traded under the ticker 7V7.

7V7 reached its all-time high on Feb 10, 2023 with the price of 10.7000 EUR, and its all-time low was 0.2040 EUR and was reached on Oct 1, 2024. View more price dynamics on 7V7 chart.
See other stocks reaching their highest and lowest prices.

Yes, you can track Acticor Biotech financials in yearly and quarterly reports right on TradingView.

Acticor Biotech is going to release the next earnings report on Sep 3, 2025. Keep track of upcoming events with our Earnings Calendar.

7V7 net income for the last half-year is ‪−7.30 M‬ EUR, while the previous report showed ‪−8.56 M‬ EUR of net income which accounts for 14.65% change. Track more Acticor Biotech financial stats to get the full picture.

No, 7V7 doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.

As of Mar 12, 2025, the company has 28.00 employees. See our rating of the largest employees — is Acticor Biotech on this list?

Like other stocks, 7V7 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Acticor Biotech stock right from TradingView charts — choose your broker and connect to your account.